Spineway SA (EPA: ALSPW)
France
· Delayed Price · Currency is EUR 0.0851
+0.0019 (2.28%)
Dec 19, 2024, 5:35 PM CET
Spineway Revenue
Spineway had revenue of 6.66M EUR in the half year ending June 30, 2024, with 84.88% growth. This brings the company's revenue in the last twelve months to 11.99M, up 8.26% year-over-year. In the year 2023, Spineway had annual revenue of 11.36M with 31.34% growth.
Revenue (ttm)
11.99M
Revenue Growth
+8.26%
P/S Ratio
0.99
Revenue / Employee
249.79K
Employees
54
Market Cap
23.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 11.36M | 2.71M | 31.34% |
| Dec 31, 2022 | 8.65M | 3.61M | 71.76% |
| Dec 31, 2021 | 5.04M | 523.00K | 11.59% |
| Dec 31, 2020 | 4.51M | -1.07M | -19.23% |
| Dec 31, 2019 | 5.59M | -1.33M | -19.17% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Eurofins Scientific SE | 6.72B |
| Ipsen S.A. | 3.44B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |